Total Payments
$4,323
2023 Payments
$14.36
Companies
29
Transactions
238
Medicare Patients
4,459
Medicare Billing
$241,558
Payment Breakdown by Category
Food & Beverage$3,940 (91.1%)
Other$348.36 (8.1%)
Education$34.73 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,940 | 233 | 91.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $348.36 | 2 | 8.1% |
| Education | $34.73 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $506.76 | 40 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $451.66 | 15 | $0 (2020) |
| Abbott Laboratories | $442.35 | 10 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $414.07 | 22 | $0 (2021) |
| GlaxoSmithKline, LLC. | $381.27 | 31 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $315.11 | 14 | $0 (2019) |
| Amarin Pharma Inc. | $266.31 | 9 | $0 (2020) |
| Allergan, Inc. | $231.60 | 16 | $0 (2020) |
| Lilly USA, LLC | $192.58 | 16 | $0 (2021) |
| Romark Laboratories, LC | $172.54 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.36 | 1 | Abbott Laboratories ($14.36) |
| 2021 | $152.27 | 8 | Novo Nordisk Inc ($64.19) |
| 2020 | $444.06 | 16 | Abbott Laboratories ($201.65) |
| 2019 | $1,561 | 68 | AstraZeneca Pharmaceuticals LP ($273.44) |
| 2018 | $1,104 | 71 | GlaxoSmithKline, LLC. ($202.34) |
| 2017 | $1,047 | 74 | AstraZeneca Pharmaceuticals LP ($160.97) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 5 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/28/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $0.09 | General |
| Category: VACCINES | ||||||
| 11/19/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/09/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/07/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 10/26/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Gout/Rheumatology | ||||||
| 10/12/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: DIABETES | ||||||
| 10/10/2018 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: GASTROINTESTINAL | ||||||
| 10/05/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Cardiology | ||||||
| 09/27/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 09/19/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Diabetes | ||||||
| 09/14/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/12/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Hyperkalemia | ||||||
| 08/30/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2018 | GlaxoSmithKline, LLC. | BREO (Drug), ADVAIR | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: DIABETES | ||||||
| 08/16/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $118.23 | General |
| Category: Hyperkalemia | ||||||
| 08/03/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: VACCINES | ||||||
| 08/01/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/26/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Diabetes | ||||||
| 07/25/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/18/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 849 | 1,057 | $104,200 | $55,473 |
| 2022 | 14 | 654 | 743 | $70,718 | $40,178 |
| 2021 | 15 | 946 | 1,138 | $97,895 | $57,508 |
| 2020 | 31 | 2,010 | 2,553 | $194,209 | $88,400 |
Total Patients
4,459
Total Services
5,491
Medicare Billing
$241,558
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 311 | $46,650 | $24,771 | 53.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $16,275 | $11,493 | 70.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 19 | $6,175 | $4,009 | 64.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 52 | $5,980 | $2,855 | 47.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 30 | $2,510 | $2,158 | 86.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 72 | 72 | $3,240 | $1,784 | 55.1% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2023 | 59 | 59 | $3,245 | $1,228 | 37.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 64 | 64 | $4,160 | $1,126 | 27.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 35 | 44 | $2,200 | $1,077 | 48.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 28 | 55 | $3,735 | $1,013 | 27.1% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 19 | 20 | $3,500 | $1,006 | 28.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 30 | $1,410 | $885.30 | 62.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 60 | 67 | $1,005 | $562.80 | 56.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 28 | $700.00 | $454.16 | 64.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 24 | 26 | $780.00 | $421.20 | 54.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 34 | $1,530 | $323.68 | 21.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 23 | $805.00 | $204.63 | 25.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 30 | $300.00 | $102.30 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 222 | $33,300 | $19,213 | 57.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 77 | 77 | $13,475 | $9,636 | 71.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 34 | $2,550 | $2,324 | 91.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 63 | 63 | $2,835 | $1,588 | 56.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 26 | 26 | $3,250 | $1,351 | 41.6% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2022 | 49 | 49 | $2,695 | $1,024 | 38.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,598 | $966.08 | 60.5% |
About Dr. Donna Mery, M.D
Dr. Donna Mery, M.D is a Family Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851364061.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donna Mery, M.D has received a total of $4,323 in payments from pharmaceutical and medical device companies, with $14.36 received in 2023. These payments were reported across 238 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,940).
As a Medicare-enrolled provider, Mery has provided services to 4,459 Medicare beneficiaries, totaling 5,491 services with total Medicare billing of $241,558. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Weslaco, TX
- Active Since 02/08/2006
- Last Updated 02/29/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1851364061
Products in Payments
- FARXIGA (Drug) $335.42
- Vascepa (Drug) $266.31
- TOUJEO (Drug) $251.89
- BREO (Drug) $226.55
- XARELTO (Drug) $189.58
- Ozempic (Drug) $183.98
- Victoza (Drug) $180.62
- Veltassa (Drug) $127.65
- TRULICITY (Drug) $122.58
- INVOKANA (Drug) $113.67
- BYSTOLIC (Drug) $107.17
- ALINIA (Drug) $106.72
- BYDUREON (Drug) $103.08
- SOLIQUA (Drug) $83.44
- JARDIANCE (Drug) $82.83
- JANUVIA (Drug) $78.88
- BELSOMRA (Drug) $70.30
- TRELEGY ELLIPTA (Drug) $67.14
- Alinia (Drug) $65.82
- SOLIQUA 100/33 (Drug) $65.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weslaco
Melecia Fuentes, M.d, M.D
Family Medicine — Payments: $7,400
Family Medicine $7,400
Dr. Alejandro Fuentes, M.d, M.D
Family Medicine — Payments: $5,116
Family Medicine $5,116
Dr. Roger Heredia, M.d, M.D
Family Medicine — Payments: $3,405
Family Medicine $3,405
Larissa Riojas, Do, DO
Family Medicine — Payments: $3,282
Family Medicine $3,282
Martha Cano, Md, MD
Family Medicine — Payments: $2,563
Family Medicine $2,563
Pamela Ramirez Stroman, M.d, M.D
Family Medicine — Payments: $2,176
Family Medicine $2,176